“Global Catalog Peptides Market By Type (Cyclic, Calcitonin gene-related, Caspase related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-microbial, G-protein-coupled receptors (GPCR), Others), By Application (Commercial discovery, Academic Research, Therapeutics), By End-User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations (CMOs) or Contract Research Organizations (CROs), Academic and Research Institutes) and Region- Global Market Size, Status and Forecast to 2026″, published by Verified Market Research.

The Global Catalog Peptides Market size is projected to grow from USD 246.93 Million in 2018 to USD 390.31 Million by 2026, at a CAGR of 6.02% from 2019 to 2026. Increased research activities to address unmet medical needs in various therapeutic areas are expected to drive market growth during the forecast period.

Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=15659&utm_source=Free&utm_medium=004

Browse in-depth TOC on “Global Catalog Peptides Market”

30– Tables
30 – Figures
68– Pages

In terms of application, the market is bifurcated into commercial, therapeutics, and academic research. The market for commercial accounted for the largest market share and expected to remain the same over the forecast period. Catalog peptides are used for various commercial applications includes antibody production, drug discovery, enzyme profiling, and others. Peptides can be used effectively as proteins in antibody production; they can aid in producing both polyclonal and monoclonal antibodies. Furthermore, emerging technologies such as peptide microarray-based technologies for effective profiling of enzyme-substrate specificity have emerged over the years, which is significantly contributing to the increased growth of the commercial segment.

There has now recently been an upsurge in the number of research activities that are being carried out, particularly in the areas of drug discovery, antibody production, disease research, and therapeutics. The increased focus on these areas area allows for novel techniques to be brought to light, a lot of which include the use of peptides and their synthesis. The increase in the number of research activities can be attributed to the increasing demand for catalog peptides, which is further augmenting the global catalog peptides market share.

Get More Information @ – https://www.verifiedmarketresearch.com/download-sample/?rid=15659&utm_source=Free&utm_medium=004
The North America region is projected to account for the largest share in the Global Catalog Peptides market during the forecast period from 2019 to 2026.

The growing initiatives for governments funding for the advancement of activities such as drug discovery, antibody production, and disease research are aiding the growth of the catalog peptides market in this region. As the penetration of catalog peptides is large both in terms of research initiatives as well as the implementation of peptides in various end-use applications, the hold that the region has in terms of catalog peptides in the global market is a dominant one

Key players

Genscript Biotech, Merck KGaA, Aapptec, Bachem Holdings, Peptides International Inc., Thermo Fisher Scientific Inc., are the key players operating in the Global Catalog Peptides market. Acquisitions and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Global Catalog Peptides Market.

Obtain Report Details @ https://www.verifiedmarketresearch.com/press-release/catalog-peptides-market/?utm_source=Free&utm_medium=004